Sclerosis, Disseminated

GPTKB entity

Statements (43)
Predicate Object
gptkbp:instanceOf gptkb:disease
gptkbp:affects central nervous system
gptkbp:alsoKnownAs gptkb:Multiple_Sclerosis
gptkbp:associatedWith gptkb:Lhermitte's_sign
spasticity
bladder dysfunction
cognitive impairment
oligoclonal bands in CSF
optic neuritis
Uhthoff's phenomenon
internuclear ophthalmoplegia
plaques in white matter
gptkbp:cause fatigue
muscle weakness
vision problems
coordination difficulties
neurological symptoms
gptkbp:characterizedBy inflammation
demyelination
gptkbp:course relapsing-remitting
primary progressive
progressive relapsing
secondary progressive
gptkbp:diagnosedBy neurological examination
MRI
lumbar puncture
gptkbp:etiology autoimmune
gptkbp:firstDescribed gptkb:Jean-Martin_Charcot
1868
gptkbp:gender more common in women
gptkbp:hasNoCure true
https://www.w3.org/2000/01/rdf-schema#label Sclerosis, Disseminated
gptkbp:ICD-10_code G35
gptkbp:onset young adults
gptkbp:prevalence 2.8 million people worldwide
gptkbp:prognosis variable
gptkbp:riskFactor genetic predisposition
environmental factors
gptkbp:treatment physical therapy
corticosteroids
immunomodulatory drugs
gptkbp:bfsParent gptkb:D009290
gptkbp:bfsLayer 8